scholarly journals Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection

2014 ◽  
Vol 88 (9) ◽  
pp. 5195-5199 ◽  
Author(s):  
A. S. Cockrell ◽  
K. M. Peck ◽  
B. L. Yount ◽  
S. S. Agnihothram ◽  
T. Scobey ◽  
...  
Keyword(s):  
Middle East ◽  
Dipeptidyl Peptidase ◽  
Middle East Respiratory Syndrome ◽  
Dipeptidyl Peptidase 4 ◽  
Coronavirus Infection ◽  
Functional Receptor

scholarly journals Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants

2017 ◽  
Vol 91 (19) ◽  
Author(s):  
Kayla M. Peck ◽  
Trevor Scobey ◽  
Jesica Swanstrom ◽  
Kara L. Jensen ◽  
Christina L. Burch ◽  
...  
Keyword(s):  
Middle East ◽  
Guinea Pig ◽  
Host Range ◽  
Dipeptidyl Peptidase ◽  
Glycosylation Site ◽  
Middle East Respiratory Syndrome ◽  
Virus Receptor ◽  
Dipeptidyl Peptidase 4 ◽  
Receptor Interactions ◽  
Species Specific

ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes dipeptidyl peptidase 4 (DPP4) as an entry receptor. While bat, camel, and human DPP4 support MERS-CoV infection, several DPP4 orthologs, including mouse, ferret, hamster, and guinea pig DPP4, do not. Previous work revealed that glycosylation of mouse DPP4 plays a role in blocking MERS-CoV infection. Here, we tested whether glycosylation also acts as a determinant of permissivity for ferret, hamster, and guinea pig DPP4. We found that, while glycosylation plays an important role in these orthologs, additional sequence and structural determinants impact their ability to act as functional receptors for MERS-CoV. These results provide insight into DPP4 species-specific differences impacting MERS-CoV host range and better inform our understanding of virus-receptor interactions associated with disease emergence and host susceptibility. IMPORTANCE MERS-CoV is a recently emerged zoonotic virus that is still circulating in the human population with an ∼35% mortality rate. With no available vaccines or therapeutics, the study of MERS-CoV pathogenesis is crucial for its control and prevention. However, in vivo studies are limited because MERS-CoV cannot infect wild-type mice due to incompatibilities between the virus spike and the mouse host cell receptor, mouse DPP4 (mDPP4). Specifically, mDPP4 has a nonconserved glycosylation site that acts as a barrier to MERS-CoV infection. Thus, one mouse model strategy has been to modify the mouse genome to remove this glycosylation site. Here, we investigated whether glycosylation acts as a barrier to infection for other nonpermissive small-animal species, namely, ferret, guinea pig, and hamster. Understanding the virus-receptor interactions for these DPP4 orthologs will help in the development of additional animal models while also revealing species-specific differences impacting MERS-CoV host range.

scholarly journals Conjugation of Human β-Defensin 2 to Spike Protein Receptor-Binding Domain Induces Antigen-Specific Protective Immunity against Middle East Respiratory Syndrome Coronavirus Infection in Human Dipeptidyl Peptidase 4 Transgenic Mice

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 635
Author(s):  
Ju Kim ◽  
Ye Lin Yang ◽  
Yongsu Jeong ◽  
Yong-Suk Jang
Keyword(s):  
Middle East ◽  
Immune Responses ◽  
Receptor Binding ◽  
Dipeptidyl Peptidase ◽  
Binding Domain ◽  
Middle East Respiratory Syndrome ◽  
Spike Protein ◽  
Receptor Binding Domain ◽  
Dipeptidyl Peptidase 4 ◽  
Protein Receptor

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory symptoms. Due to the lack of medical countermeasures, effective and safe vaccines against MERS-CoV infection are urgently required. Although different types of candidate vaccines have been developed, their immunogenicity is limited, and the dose and administration route need optimization to achieve optimal protection. We here investigated the potential use of human β-defensin 2 (HBD 2) as an adjuvant to enhance the protection provided by MERS-CoV vaccination. We found that immunization of human dipeptidyl peptidase 4 (hDPP4)-transgenic (hDPP4-Tg) mice with spike protein receptor-binding domain (S RBD) conjugated with HBD 2 (S RBD-HBD 2) induced potent antigen (Ag)-specific adaptive immune responses and protected against MERS-CoV infection. In addition, immunization with S RBD-HBD 2 alleviated progressive pulmonary fibrosis in the lungs of MERS-CoV-infected hDPP4-Tg mice and suppressed endoplasmic reticulum stress signaling activation upon viral infection. Compared to intramuscular administration, intranasal administration of S RBD-HBD 2 induced more potent mucosal IgA responses and was more effective for protecting against intranasal MERS-CoV infection. In conclusion, our findings suggest that HBD 2 potentiates Ag-specific immune responses against viral Ag and can be used as an adjuvant enhancing the immunogenicity of subunit vaccine candidates against MERS-CoV.

scholarly journals Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels

2016 ◽  
Vol 90 (9) ◽  
pp. 4838-4842 ◽  
Author(s):  
W. Widagdo ◽  
V. Stalin Raj ◽  
Debby Schipper ◽  
Kimberley Kolijn ◽  
Geert J. L. H. van Leenders ◽  
...  
Keyword(s):  
Middle East ◽  
Respiratory Tract ◽  
Differential Expression ◽  
Dipeptidyl Peptidase ◽  
Middle East Respiratory Syndrome ◽  
Upper Respiratory Tract ◽  
Dromedary Camels ◽  
Dipeptidyl Peptidase 4 ◽  
Upper Respiratory

Middle East respiratory syndrome coronavirus (MERS-CoV) is not efficiently transmitted between humans, but it is highly prevalent in dromedary camels. Here we report that the MERS-CoV receptor—dipeptidyl peptidase 4 (DPP4)—is expressed in the upper respiratory tract epithelium of camels but not in that of humans. Lack of DPP4 expression may be the primary cause of limited MERS-CoV replication in the human upper respiratory tract and hence restrict transmission.

scholarly journals Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus

2013 ◽  
Vol 88 (3) ◽  
pp. 1834-1838 ◽  
Author(s):  
V. S. Raj ◽  
S. L. Smits ◽  
L. B. Provacia ◽  
J. M. A. van den Brand ◽  
L. Wiersma ◽  
...  
Keyword(s):  
Middle East ◽  
Adenosine Deaminase ◽  
Dipeptidyl Peptidase ◽  
Middle East Respiratory Syndrome ◽  
Dipeptidyl Peptidase 4

scholarly journals Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4

2014 ◽  
Vol 88 (16) ◽  
pp. 9220-9232 ◽  
Author(s):  
N. van Doremalen ◽  
K. L. Miazgowicz ◽  
S. Milne-Price ◽  
T. Bushmaker ◽  
S. Robertson ◽  
...  
Keyword(s):  
Middle East ◽  
Host Species ◽  
Dipeptidyl Peptidase ◽  
Middle East Respiratory Syndrome ◽  
Dipeptidyl Peptidase 4

scholarly journals Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus

2019 ◽  
Vol 93 (6) ◽  
Author(s):  
Naoko Iwata-Yoshikawa ◽  
Tadashi Okamura ◽  
Yukiko Shimizu ◽  
Osamu Kotani ◽  
Hironori Sato ◽  
...  
Keyword(s):  
Animal Model ◽  
Middle East ◽  
Mouse Model ◽  
Transgenic Mice ◽  
Respiratory Tract ◽  
Dipeptidyl Peptidase ◽  
Middle East Respiratory Syndrome ◽  
Human Tissues ◽  
Disease Pathogenesis ◽  
Dipeptidyl Peptidase 4

ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) infection can manifest as a mild illness, acute respiratory distress, organ failure, or death. Several animal models have been established to study disease pathogenesis and to develop vaccines and therapeutic agents. Here, we developed transgenic (Tg) mice on a C57BL/6 background; these mice expressed human CD26/dipeptidyl peptidase 4 (hDPP4), a functional receptor for MERS-CoV, under the control of an endogenous hDPP4 promoter. We then characterized this mouse model of MERS-CoV. The expression profile of hDPP4 in these mice was almost equivalent to that in human tissues, including kidney and lung; however, hDPP4 was overexpressed in murine CD3-positive cells within peripheral blood and lymphoid tissues. Intranasal inoculation of young and adult Tg mice with MERS-CoV led to infection of the lower respiratory tract and pathological evidence of acute multifocal interstitial pneumonia within 7 days, with only transient loss of body weight. However, the immunopathology in young and adult Tg mice was different. On day 5 or 7 postinoculation, lungs of adult Tg mice contained higher levels of proinflammatory cytokines and chemokines associated with migration of macrophages. These results suggest that the immunopathology of MERS-CoV infection in the Tg mouse is age dependent. The mouse model described here will increase our understanding of disease pathogenesis and host mediators that protect against MERS-CoV infection. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) infections are endemic in the Middle East and a threat to public health worldwide. Rodents are not susceptible to the virus because they do not express functional receptors; therefore, we generated a new animal model of MERS-CoV infection based on transgenic mice expressing human DPP4 (hDPP4). The pattern of hDPP4 expression in this model was similar to that in human tissues (except lymphoid tissue). In addition, MERS-CoV was limited to the respiratory tract. Here, we focused on host factors involved in immunopathology in MERS-CoV infection and clarified differences in antiviral immune responses between young and adult transgenic mice. This new small-animal model could contribute to more in-depth study of the pathology of MERS-CoV infection and aid development of suitable treatments.

Sign in / Sign up

Export Citation Format

Share Document